The study populations were T2D patients prescribed semaglutide or non-GLP-1 RA anti-diabetic medicines and obese/overweight patients prescribed semaglutide or non-GLP-1 RA weight loss medicines
Patients with specific health conditions or weight loss goals may benefit more from one over the other
We focus on helping you achieve safe, sustainable results while building healthy habits that last, all in a welcoming, patient-centered environment
Semaglutide is a GLP-1 receptor agonist , which means it works with hormone pathways involved in appetite, fullness, digestion, and blood sugar response
This package is perfect for those who need a quick pick-me-up after a long flight or a tough workout
Most patients begin at a low dose to minimize nausea and gradually increase as their body adapts